Rakesh Luthra, MS

Director, HEOR Strategy
Novo Nordisk Inc.

Poster(s):

• (389) Healthcare Resource Utilization and Costs in Patients with Metabolic Dysfunction Associated Steatohepatitis: A Comparison Between Patients with Diagnosed MASH, Probable MASH, and Without MASH
  Wednesday, October 29, 2025